Intracerebroventricular administration of the β3-adrenoceptor agonist CL 316243 causes Fos immunoreactivity in discrete regions of rat hypothalamus

Margie Castillo-Meléndez, Michael J. McKinley, Roger J. Summers

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)


Intracerebroventricular (i.c.v.) administration of the β3-AR agonist BRL37344 causes dose dependent decreases in food intake in rats suggesting a role for β3-AR in the central control of feeding. We have conducted experiments investigating the effects of i.c.v. administration of the selective β3-AR agonist CL316243 on Fos expression to determine whether β3-AR stimulation affects neurones within specific brain nuclei. Significantly higher numbers of Fos positive cells were found in the rats treated i.c.v. with CL316243 compared with control rats in the paraventricular hypothalamus, lateral hypothalamic area, ventromedial hypothalamic nucleus and dorsal hypothalamic area. Pre-treatment with the selective β3-AR antagonist SR59230A resulted in a significant decrease in the number of Fos positive cells in all those areas compared with rats treated with CL316243 alone. These experiments demonstrate that i.c.v. administration of selective β3-AR agonist causes neuronal activation in hypothalamic areas important in the central regulation of appetite via a β3-AR mediated effect. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)161-164
Number of pages4
JournalNeuroscience Letters
Issue number3
Publication statusPublished - 1 Sep 2000


  • Adrenergic
  • Brain, Fos
  • Immunohistochemistry
  • Rat
  • β-Adrenoceptor

Cite this